Literature DB >> 71448

Vitamin-D metabolism in nephrotic syndrome.

J M Barragry, M W France, N D Carter, J A Auton, M Beer, B J Boucher, R D Cohen.   

Abstract

Plasma concentrations of 25-hydroxy-cholecalciferol (25-OHD3) and vitamin-D-binding globulin (V.D.B.G.) were significantly reduced in ten nephrotic subjects. V.D.B.G., which is undetectable in normal urine, was present in substantial amounts in the urine of each nephrotic subject. Administration of 3H-labelled cholecalciferol to three subjects resulted in the rapid appearance of the labelled vitamin in the urine, mainly as the 25-hydroxylated metabolite bound to V.D.B.G. in amounts which could largely account for the low plasma-25-OHD3. The plasma half-life of 25-OHD3 was substantially reduced in the nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71448     DOI: 10.1016/s0140-6736(77)92498-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

2.  Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.

Authors:  Surabhi Choudhary; Indira Agarwal; Mandalam S Seshadri
Journal:  Pediatr Nephrol       Date:  2014-01-12       Impact factor: 3.714

3.  Free vitamin D levels in steroid-sensitive nephrotic syndrome and healthy controls.

Authors:  Sushmita Banerjee; Surupa Basu; Shakil Akhtar; Rajiv Sinha; Ananda Sen; Jayati Sengupta
Journal:  Pediatr Nephrol       Date:  2019-12-16       Impact factor: 3.714

4.  Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis.

Authors:  Agnieszka Prytuła; David Wells; Timothy McLean; Filipa Balona; Ambrose Gullett; Craig Knott; Michelle Cantwell; Kimberly Hassen; Sarah Ledermann; Lesley Rees; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2011-11-15       Impact factor: 3.714

5.  Serum 25 (OH) D and 24,25 (OH)2 levels in childhood nephrosis under different therapeutic regimens of steroid administration.

Authors:  K Kano; T Suda
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

6.  Vitamin D in nephrotic syndrome remission: a case-control study.

Authors:  Sushmita Banerjee; Surupa Basu; Jayati Sengupta
Journal:  Pediatr Nephrol       Date:  2013-05-25       Impact factor: 3.714

7.  Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth.

Authors:  O G Brooke; I R Brown; C D Bone; N D Carter; H J Cleeve; J D Maxwell; V P Robinson; S M Winder
Journal:  Br Med J       Date:  1980-03-15

8.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.

Authors:  H H Malluche; D A Goldstein; S G Massry
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

10.  Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.

Authors:  Michael Freundlich; Michael Jofe; William G Goodman; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.